Palatin Technologies Inc - ESG Rating & Company Profile powered by AI
This article includes a Q&A section for Palatin Technologies Inc. This Sustainability rating for Palatin Technologies Inc indicates the company's reporting of the United Nations SDGs. The analysis of Palatin Technologies Inc is assembled by All Street Sevva using cutting edge AI.
Palatin Technologies Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.9; made up of an environmental score of 2.7, social score of 8.0 and governance score of 4.0.
4.9
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 744 | Sopharma AD | 5.0 | High |
| 744 | vTv Therapeutics Inc | 5.0 | High |
| 764 | Palatin Technologies Inc | 4.9 | High |
| 764 | BetterLife Pharma Inc | 4.9 | High |
| 764 | Acerus Pharmaceuticals Corporation | 4.9 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Palatin Technologies Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Palatin Technologies Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Palatin Technologies Inc report the average age of the workforce?
Sign up for free to unlockDoes Palatin Technologies Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Palatin Technologies Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Palatin Technologies Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Palatin Technologies Inc offer flexible work?
Sign up for free to unlockDoes Palatin Technologies Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Palatin Technologies Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Palatin Technologies Inc conduct supply chain audits?
Sign up for free to unlockDoes Palatin Technologies Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Palatin Technologies Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Palatin Technologies Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Palatin Technologies Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Palatin Technologies Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Palatin Technologies Inc disclose water use targets?
Sign up for free to unlockDoes Palatin Technologies Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Palatin Technologies Inc have a product recall in the last two years?
Sign up for free to unlockDoes Palatin Technologies Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Palatin Technologies Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Palatin Technologies Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Palatin Technologies Inc disclose parental leave metrics?
Sign up for free to unlockDoes Palatin Technologies Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Palatin Technologies Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Palatin Technologies Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Palatin Technologies Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Palatin Technologies Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Palatin Technologies Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Palatin Technologies Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Palatin Technologies Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Palatin Technologies Inc disclose its waste policy?
Sign up for free to unlockDoes Palatin Technologies Inc report according to TCFD requirements?
Sign up for free to unlockDoes Palatin Technologies Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Palatin Technologies Inc disclose energy use targets?
Sign up for free to unlockDoes Palatin Technologies Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Palatin Technologies Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Palatin Technologies Inc
These potential risks are based on the size, segment and geographies of the company.
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL3994, a peptide mimetic molecule with amino acid mimetic structure and amino acids properties; and L8177, an oral peptide formulation for treatment of ulcerative colitis, which entered Phase 2 clinical trials. The company was founded in 1986 and is based in Cranbury, New Jersey.